Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis.

Kasprzak A, Adamek A.

Int J Mol Sci. 2019 Mar 14;20(6). pii: E1288. doi: 10.3390/ijms20061288. Review.

2.

Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy.

Kasprzak A, Adamek A.

Int J Mol Sci. 2018 Dec 5;19(12). pii: E3887. doi: 10.3390/ijms19123887. Review.

3.

Insulin-Like Growth Factor (IGF) System in Liver Diseases.

Adamek A, Kasprzak A.

Int J Mol Sci. 2018 Apr 27;19(5). pii: E1308. doi: 10.3390/ijms19051308. Review.

4.

Tissue expression of β-catenin and E- and N-cadherins in chronic hepatitis C and hepatocellular carcinoma.

Kasprzak A, Rogacki K, Adamek A, Sterzyńska K, Przybyszewska W, Seraszek-Jaros A, Helak-Łapaj C, Pyda P.

Arch Med Sci. 2017 Oct;13(6):1269-1280. doi: 10.5114/aoms.2017.65272. Epub 2017 Jan 19.

5.

Insulin-like growth factor (IGF) axis in cancerogenesis.

Kasprzak A, Kwasniewski W, Adamek A, Gozdzicka-Jozefiak A.

Mutat Res Rev Mutat Res. 2017 Apr - Jun;772:78-104. doi: 10.1016/j.mrrev.2016.08.007. Epub 2016 Sep 4. Review.

PMID:
28528692
6.

The prevalence of mixed genotype infections in Polish patients with hepatitis C.

Gowin E, Bereszyńska I, Adamek A, Kowala-Piaskowska A, Mozer-Lisewska I, Wysocki J, Michalak M, Januszkiewicz-Lewandowska D.

Int J Infect Dis. 2016 Feb;43:13-16. doi: 10.1016/j.ijid.2015.12.007. Epub 2015 Dec 14.

7.

Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C.

Kasprzak A, Adamek A, Przybyszewska W, Pyda P, Szmeja J, Seraszek-Jaros A, Lanzafame A, Surdacka A, Mozer-Lisewska I, Koczorowska M.

World J Gastroenterol. 2015 Apr 7;21(13):3867-75. doi: 10.3748/wjg.v21.i13.3867.

8.

The insulin-like growth factor-1 and expression of its binding protein‑3 in chronic hepatitis C and hepatocellular carcinoma.

Adamek A, Kasprzak A, Mikoś H, Przybyszewska W, Seraszek-Jaros A, Czajka A, Sterzyńska K, Mozer-Lisewska I.

Oncol Rep. 2013 Sep;30(3):1337-45. doi: 10.3892/or.2013.2546. Epub 2013 Jun 19.

PMID:
23784592
9.

Distribution of HCV genotypes in Poland.

Panasiuk A, Flisiak R, Mozer-Lisewska I, Adamek A, Tyczyno M, Halota W, Pawłowska M, Stańczak J, Berak H, Wawrzynowicz-Syczewska M, Boroń-Kaczmarska A, Łapiński TW, Grzeszczuk A, Piekarska A, Tomasiewicz K, Jabłkowski M, Kryczka W, Zarebska-Michaluk D, Stepień P, Garlicki AM, Kozłowska J, Wiercińska-Drapało A, Zasik E, Mazur W, Dobracka B, Dobracki W, Simon K, Ryzko J, Pawłowska J, Dzierzanowska-Fangrat K, Januszkiewicz-Lewandowska D, Szenborn L, Zaleska I, Rokitka M, Strawińska E, Balinowska K, Smiatacz T, Stalke P, Sikorska K, Lakomy A, Zdrojewski M, Lachowicz A.

Przegl Epidemiol. 2013;67(1):11-6, 99-103. English, Polish.

10.

Seroprevalence of hepatitis A virus antibodies (anti-HAV) in adult inhabitants of Wielkopolska region, Poland--the role of simple demographic factors.

Bura M, Bura A, Adamek A, Michalak M, Marszałek A, Hryckiewicz K, Mozer-Lisewska I.

Ann Agric Environ Med. 2012;19(4):738-41.

11.

The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (review).

Kasprzak A, Adamek A.

Int J Oncol. 2012 Dec;41(6):1919-31. doi: 10.3892/ijo.2012.1666. Epub 2012 Oct 16. Review.

PMID:
23076735
12.

Results of antiviral treatment of patients with chronic hepatitis C: experience of Poznan centre.

Bura M, Kowala-Piaskowska A, Adamek A, Bura A, Czajka A, Hryckiewicz K, Bereszyńska I, Mozer-Lisewska I.

Postepy Hig Med Dosw (Online). 2012 Jun 14;66:339-47.

13.

Alterations of insulin-like growth factor I (IGF-I) and estradiol serum levels in chronic hepatitis C.

Adamek A, Kasprzak A, Seraszek A, Mikoś H, Bura A, Mozer-Lisewska I.

Contemp Oncol (Pozn). 2012;16(3):234-9. doi: 10.5114/wo.2012.29291. Epub 2012 Jul 6.

14.

Polysaccharides and mucin 5AC (MUC5AC) expression in gallbladder mucosa of young patients with gallstones as evaluated by spatial visualization and quantification.

Kasprzak A, Malkowski W, Helak-Łapaj C, Seraszek A, Kaczmarek E, Adamek A, Zabel M.

Folia Histochem Cytobiol. 2010 Dec;48(4):646-57. doi: 10.2478/v10042-010-0053-8.

15.

p21/Wafl/Cipl cellular expression in chronic long-lasting hepatitis C: correlation with HCV proteins (C, NS3, NS5A), other cell-cycle related proteins and selected clinical data.

Kasprzak A, Adamek A, Przybyszewska W, Olejniczak K, Biczysko W, Mozer-Lisewska I, Zabel M.

Folia Histochem Cytobiol. 2009 Jan;47(3):385-94. doi: 10.2478/v10042-009-0096-x.

16.

p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection.

Kasprzak A, Adamek A, Przybyszewska W, Czajka A, Olejniczak K, Juszczyk J, Biczysko W, Zabel M.

Folia Histochem Cytobiol. 2009;47(1):35-42. doi: 10.2478/v10042-009-0003-5.

17.

[Long-term viral response to interferon alpha 2b plus ribavirin in chronic hepatitis C patients during standard therapy].

Adamek A, Adamek J, Juszczyk J, Bereszyńska I.

Przegl Epidemiol. 2007;61(4):765-70. Polish.

PMID:
18572509
18.

Intracellular expression of the proliferative marker Ki-67 and viral proteins (NS3, NS5A and C) in chronic, long lasting hepatitis C virus (HCV) infection.

Kasprzak A, Adamek A, Biczysko W, Seidel J, Przybyszewska W, Olejniczak K, Juszczyk J, Zabel M.

Folia Histochem Cytobiol. 2007;45(4):357-66.

19.

Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis.

Kasprzak A, Adamek A.

Hepatol Res. 2008 Jan;38(1):1-26. Epub 2007 Sep 25.

PMID:
17894800
20.

Interleukin-2 (IL-2) expression in livers of patients with chronic hepatitis C virus (HCV) infection.

Kasprzak A, Seidel J, Adamek A, Biczysko W, Wysocki J, Spachacz R, Juszczyk J, Zabel M.

Folia Histochem Cytobiol. 2006;44(2):103-10.

Supplemental Content

Loading ...
Support Center